![Catherine Pearson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Catherine Pearson via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Washington University in St. Louis | College/University | Corporate Officer/Principal | |
OxoN Medica, Inc. | Private Equity Investor | ||
TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
Optivia Biotechnology, Inc.
![]() Optivia Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Optivia Biotechnology, Inc. provides contract research organization offering drug transporter research services and solutions to biotechnology, pharmaceutical and academic organizations. It offers regulatory DDI studies, transporter screening, tranporter profiling, and custom development services. The firm's products include TransFlex Single Transporter Assay Plates,TransFlex Multi-Transporter Model Plates, and Certified Efflux Transporter Vesicles. The company was founded by Yong Huang, Pascal Druzgala and Peter G. Milner in 2007 and is headquartered in Santa Clara, CA. | Pharmaceuticals: Major | Founder Founder | |
Stanford University | College/University | Corporate Officer/Principal | |
The University of Liverpool
![]() The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree | |
Xenon Vision, Inc.
![]() Xenon Vision, Inc. Miscellaneous Commercial ServicesCommercial Services Part of W World Corp., Xenon Vision, Inc. is a vision research concern. The company is based in Alachua, FL. Xenon Vision was acquired by Pharmatec, Inc. on November 03, 1992. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder | |
University of Leeds | College/University | Undergraduate Degree | |
University of London | College/University | Doctorate Degree | |
University of Florida | College/University | Doctorate Degree | |
Université de Montpellier | College/University | Doctorate Degree | |
University of Durham | College/University | Masters Business Admin | |
ABV LLC
![]() ABV LLC Investment ManagersFinance ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
Lifeline Technologies, Inc.
![]() Lifeline Technologies, Inc. BiotechnologyHealth Technology Lifeline Technologies, Inc. operates as a health sciences development company which focuses on novel strategies. It offers ChoLESStolife, a non-prescription and non-synthetic cholesterol absorption inhibitor for the reduction of human cholesterol using a fat-free delivery system for soy sterols and stanols. The company was registered by Curtis A. Spilburg and Richard E. Ostlund on October 1, 2002 and is headquartered in Hendersonville, NC. | Biotechnology | Director/Board Member | |
Ischemix, Inc.
![]() Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Pharmaceuticals: Major | Director/Board Member | |
Advanced Therapies, Inc. | Founder | ||
Retrotope, Inc.
![]() Retrotope, Inc. Pharmaceuticals: MajorHealth Technology Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Atheneos Ventures LLC
![]() Atheneos Ventures LLC Investment ManagersFinance Atheneos Ventures LLC (Atheneos Ventures) is a venture capital firm founded in 2009. The firm is headquartered in Santa Clara, California. | Investment Managers | Private Equity Investor | |
SinuSys Corp.
![]() SinuSys Corp. Medical SpecialtiesHealth Technology SinuSys Corp. develops medical device therapies to improve the sinus health of patients with chronic sinusitis. Its products include Vent-OS sinus dilation system, Restora steroid-eluting spacer, and SinuSys product pipeline. The company was founded by Jerome Hester and Thomas A. Schreck in 2010 and is headquartered in Palo Alto, CA. | Medical Specialties | Director/Board Member | |
AshHill Investments LLC
![]() AshHill Investments LLC Investment ManagersFinance AshHill Investments LLC (AshHill Investments) is a venture capital firm founded in 2011. The firm is headquartered in Ft. Thomas, Kentucky. | Investment Managers | Chief Executive Officer | |
Armetheon, Inc.
![]() Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA. | Pharmaceuticals: Major | Founder Founder President | |
Renexxion LLC
![]() Renexxion LLC Pharmaceuticals: MajorHealth Technology Renexxion LLC is a gastrointestinal biopharmaceutical company. It develops naronapride. The company was founded by Peter G. Milner, Muralitharan Kengatharan , and Pascal J. Druzgala in 2014 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Founder Founder Chairman | |
Spire Bioventures, Inc.
![]() Spire Bioventures, Inc. Miscellaneous Commercial ServicesCommercial Services Spire Bioventures, Inc. provides consulting services for the healthcare industry. | Miscellaneous Commercial Services | Consultant / Advisor | |
Auxesia Orion, Inc.
![]() Auxesia Orion, Inc. Information Technology ServicesTechnology Services Auxesia Orion, Inc. offers intelligent therapeutic management for patients with orphan diseases. | Information Technology Services | Chairman | |
Helios Orion Corp.
![]() Helios Orion Corp. Miscellaneous Commercial ServicesCommercial Services Helios Orion Corp. is a corporate strategy advisory firm that partners with innovative healthcare companies in key markets to assist in their growth. The company is based in Santa Clara, CA. The company's experienced team provides plug and play solutions to help these companies succeed. | Miscellaneous Commercial Services | Chairman |
Statistiques
Internationale
Etats-Unis | 25 |
Royaume-Uni | 6 |
Canada | 2 |
France | 2 |
Irlande | 2 |
Sectorielle
Health Technology | 15 |
Consumer Services | 9 |
Commercial Services | 5 |
Finance | 4 |
Technology Services | 2 |
Opérationnelle
Director/Board Member | 19 |
Founder | 13 |
Chief Tech/Sci/R&D Officer | 8 |
Corporate Officer/Principal | 7 |
Chairman | 6 |
Relations les plus connectées
- Bourse
- Insiders
- Catherine Pearson
- Connexions Sociétés